These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 26451106)

  • 21. Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment.
    Jiang X; Xin H; Ren Q; Gu J; Zhu L; Du F; Feng C; Xie Y; Sha X; Fang X
    Biomaterials; 2014 Jan; 35(1):518-29. PubMed ID: 24125772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A blood-brain barrier- and blood-brain tumor barrier-penetrating siRNA delivery system targeting gliomas for brain tumor immunotherapy.
    Tang L; Zhang R; Wang Y; Liu M; Hu D; Wang Y; Yang L
    J Control Release; 2024 May; 369():642-657. PubMed ID: 38575072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2.
    Ren J; Shen S; Wang D; Xi Z; Guo L; Pang Z; Qian Y; Sun X; Jiang X
    Biomaterials; 2012 Apr; 33(11):3324-33. PubMed ID: 22281423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells.
    Basha G; Novobrantseva TI; Rosin N; Tam YY; Hafez IM; Wong MK; Sugo T; Ruda VM; Qin J; Klebanov B; Ciufolini M; Akinc A; Tam YK; Hope MJ; Cullis PR
    Mol Ther; 2011 Dec; 19(12):2186-200. PubMed ID: 21971424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery.
    Cheng X; Lee RJ
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):129-137. PubMed ID: 26900977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Charge-reversible lipid derivative: A novel type of pH-responsive lipid for nanoparticle-mediated siRNA delivery.
    Hirai Y; Saeki R; Song F; Koide H; Fukata N; Tomita K; Maeda N; Oku N; Asai T
    Int J Pharm; 2020 Jul; 585():119479. PubMed ID: 32473372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA.
    Kulkarni JA; Darjuan MM; Mercer JE; Chen S; van der Meel R; Thewalt JL; Tam YYC; Cullis PR
    ACS Nano; 2018 May; 12(5):4787-4795. PubMed ID: 29614232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma.
    Huang S; Li J; Han L; Liu S; Ma H; Huang R; Jiang C
    Biomaterials; 2011 Oct; 32(28):6832-8. PubMed ID: 21700333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delivering siRNA and Chemotherapeutic Molecules Across BBB and BTB for Intracranial Glioblastoma Therapy.
    Yang ZZ; Gao W; Liu YJ; Pang N; Qi XR
    Mol Pharm; 2017 Apr; 14(4):1012-1022. PubMed ID: 28252970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles.
    Jin J; Bae KH; Yang H; Lee SJ; Kim H; Kim Y; Joo KM; Seo SW; Park TG; Nam DH
    Bioconjug Chem; 2011 Dec; 22(12):2568-72. PubMed ID: 22070554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A QCM-D and SAXS Study of the Interaction of Functionalised Lyotropic Liquid Crystalline Lipid Nanoparticles with siRNA.
    Tajik-Ahmadabad B; Mechler A; Muir BW; McLean K; Hinton TM; Separovic F; Polyzos A
    Chembiochem; 2017 May; 18(10):921-930. PubMed ID: 28233412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitation of physiological and biochemical barriers to siRNA liver delivery via lipid nanoparticle platform.
    Xu Y; Ou M; Keough E; Roberts J; Koeplinger K; Lyman M; Fauty S; Carlini E; Stern M; Zhang R; Yeh S; Mahan E; Wang Y; Slaughter D; Gindy M; Raab C; Thompson C; Hochman J
    Mol Pharm; 2014 May; 11(5):1424-34. PubMed ID: 24588618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas.
    Li Y; He H; Jia X; Lu WL; Lou J; Wei Y
    Biomaterials; 2012 May; 33(15):3899-908. PubMed ID: 22364698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides.
    Zhu Y; Jiang Y; Meng F; Deng C; Cheng R; Zhang J; Feijen J; Zhong Z
    J Control Release; 2018 May; 278():1-8. PubMed ID: 29596873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound.
    Timbie KF; Afzal U; Date A; Zhang C; Song J; Wilson Miller G; Suk JS; Hanes J; Price RJ
    J Control Release; 2017 Oct; 263():120-131. PubMed ID: 28288892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retro-inverso isomer of Angiopep-2: a stable d-peptide ligand inspires brain-targeted drug delivery.
    Wei X; Zhan C; Chen X; Hou J; Xie C; Lu W
    Mol Pharm; 2014 Oct; 11(10):3261-8. PubMed ID: 24673510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineered nanoparticles for systemic siRNA delivery to malignant brain tumours.
    Karlsson J; Rui Y; Kozielski KL; Placone AL; Choi O; Tzeng SY; Kim J; Keyes JJ; Bogorad MI; Gabrielson K; Guerrero-Cazares H; Quiñones-Hinojosa A; Searson PC; Green JJ
    Nanoscale; 2019 Nov; 11(42):20045-20057. PubMed ID: 31612183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles.
    Ruan S; Yuan M; Zhang L; Hu G; Chen J; Cun X; Zhang Q; Yang Y; He Q; Gao H
    Biomaterials; 2015 Jan; 37():425-35. PubMed ID: 25453970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.
    Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z
    Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.